Efficacy and Safety of GZR18 Every 2 Weeks Versus Tirzepatide and Placebo in Obese or Overweight Participants
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Tirzepatide
Related studies linked through entity extraction aliases.
Safety and Efficacy of NA-931 and Tirzepatide in Adults Who Are Overweight or Obese
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Study of Tirzepatide for Recovery and Alcohol Use Management
- Status
- RECRUITING
- Phase
- PHASE2
2024 Tirzepatide-Bariatric Surgery
- Status
- RECRUITING
- Phase
- PHASE4
A First-In-Human Study of ARO-INHBE in Adults With Obesity With and Without Type 2 Diabetes Mellitus
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study of Retatrutide (LY3437943) Compared to Tirzepatide (LY3298176) in Adults Who Have Obesity
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Normal-weight Diabetes: Adipocyte-directed Therapy With Pioglitazone or Tirzepatide
- Status
- RECRUITING
- Phase
- PHASE4
Evaluation of Tirzepatide as an Adjunct to Buprenorphine for the Treatment of Opioid Use Disorder
- Status
- RECRUITING
- Phase
- PHASE2
A Study to Investigate Weight Management With Bimagrumab (LY3985863) and Tirzepatide (LY3298176), Alone or in Combination, in Adults With Obesity or Overweight
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes During Ramadan
- Status
- COMPLETED
- Phase
- PHASE4
GIP/GLP-1RA as Adjunctive to Automated Insulin Delivery in Adults With Type 1 Diabetes
- Status
- RECRUITING
- Phase
- PHASE3
The Effects of Tirzepatide in People With Overweight/Obesity and Coronary Artery Disease
- Status
- RECRUITING
- Phase
- PHASE4
A Study to Investigate Weight Management With LY3841136 and Tirzepatide (LY3298176), Alone or in Combination, in Adult Participants With Obesity or Overweight With Type 2 Diabetes
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Ixekizumab Concomitantly Administered With Tirzepatide in Adults With Psoriatic Arthritis and Obesity or Overweight
- Status
- COMPLETED
- Phase
- PHASE3
Ixekizumab Concomitantly Administered With Tirzepatide in Adults With Moderate-to-Severe Plaque Psoriasis and Obesity or Overweight
- Status
- COMPLETED
- Phase
- PHASE3
Glucagon-Like Peptide-1 Receptor Agonist in ADPKD
- Status
- RECRUITING
- Phase
- PHASE2
A Phase 2 Study Evaluating the Co-Administration of Bremelanotide With Tirzepatide for the Treatment of Obesity
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Tirzepatide in People With Type 2 Diabetes Treated With Metformin, SGLT2 Inhibitor or Both
- Status
- COMPLETED
- Phase
- PHASE3
Tirzepatide for Weight Loss Intervention in Early-Stage Hormone Receptor Positive/HER2 Negative Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Tirzepatide Weight Loss for MRD+ Early Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE2